# PATHOS (NCT02215265)

> Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02215265
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Lisette Nixon
- Conditions: Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
- Interventions: Cisplatin; Postoperative radiotherapy
- Enrollment: 1269
- Primary outcome: MDADI/Overall survival co-primary endpoint

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 11
- Podcasts: 2
- YouTube: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=pathos-nct02215265

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02215265", "email": "<work email>"}; the inbox owner confirms by the emailed link.